# Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

> **NCT04859218** · NA · RECRUITING · sponsor: **McMaster University** · enrollment: 30 (estimated)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **PROCEDURE:** RBC transfusion

## Key facts

- **NCT ID:** NCT04859218
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-17
- **Primary completion:** 2025-07
- **Final completion:** 2025-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04859218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04859218, "Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04859218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*